55 Stocks Moving In Friday's Mid-Day Session

Loading...
Loading...

Gainers

  • Wellesley Bancorp, Inc. WEBK shares climbed 29.1% to $41.70. Cambridge Trust announced plans to acquire Wellesley Bank for $122 million.
  • Cassava Sciences, Inc. SAVA shares gained 29.7% to $2.3350 after the company announced additional positive Phase 2a clinical data in Alzheimer's disease at the CTAD 2019.
  • Genesco Inc. GCO gained 27.4% to $47.07 after the company reported upbeat Q3 earnings and issued strong FY20 EPS forecast.
  • Big Lots, Inc. BIG rose 25.8% to $24.10 after the company reported upbeat results for its third quarter.
  • KLX Energy Services Holdings, Inc. KLXE surged 24.4% to $5.26 after OPEC and OPEC+ agreed to further oil production cuts.
  • Cancer Genetics, Inc. CGIX rose 22.1% to $6.73.
  • Onconova Therapeutics Inc ONTX gained 20.5% to $0.3520 after the company announced it has entered into a collaboration agreement with Inceptua Medicines Access to make available intravenous rigosertib via pre-approval access program in selected countries.
  • EZCORP, Inc. EZPW rose 19.5% to $6.25 following Q4 earnings.
  • Sierra Oncology Inc SRRA surged 19.1% to $0.4562 after Oppenheimer initiated coverage on the company's stock with an Outperform rating and a $1.20 price target.
  • Domo, Inc. DOMO rose 16.7% to $22.76 after the company reported Q3 EPS and sales results. The company also issued Q4 EPS and sales guidance above analyst estimates.
  • Epizyme, Inc. EPZM gained 14.2% to $17.48 after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and raised the price action from $12 to $22 per share.
  • Clovis Oncology, Inc. CLVS gained 13.7% to $10.07 in sympathy with the overall market after the U.S. added 266,000 jobs in November, beating expectations and lowering the unemployment rate to 3.5%.
  • The Chemours Company CC climbed 13.3% to $17.06 on reports stating the House is said to be easing 'Forever chemical' wording.
  • Lexicon Pharmaceuticals, Inc. LXRX rose 12.7% to $4.77 on continued momentum after the company reported the topline Phase 1 data for its LX9211. NOTE: The study showed favorable safety results.
  • Hovnanian Enterprises, Inc. HOV gained 12.7% to $28.14. Buckingham maintained Hovnanian with a Neutral and raised the price target from $24 to $27.
  • PolarityTE, Inc. PTE surged 12.3% to $2.9081.
  • Ulta Beauty, Inc. ULTA rose 12% to $264.34 after the company reported better-than-expected Q3 EPS results. The company also narrowed its FY19 EPS guidance above analyst estimates.
  • Harpoon Therapeutics, Inc. HARP climbed 11.4% to $19.96.
  • Rocket Pharmaceuticals, Inc. RCKT gained 10.4% to $21.76. Rocket Pharma reported that first patient has been treated in global registrational Phase 2 study of RP-L102 for fanconi anemia.
  • Evolent Health, Inc. EVH shares climbed 10.3% to $7.37 in sympathy with the overall market after the U.S. added 266,000 jobs in November, beating expectations and lowering the unemployment rate to 3.5%.
  • Zumiez Inc. ZUMZ rose 10.3% to $33.71 after the company reported stronger-than-expected Q3 results and issued Q4 EPS guidance above analyst estimates.
  • Avadel Pharmaceuticals plc AVDL gained 10% to $6.34.
  • National Beverage Corp. FIZZ climbed 9.6% to $52.89 following Q2 results.
  • Progyny, Inc. PGNY gained 9.6% to $30.54.
  • Puma Biotechnology, Inc. PBYI rose 8.6% to $8.08. H.C. Wainwright initiated coverage on Puma Biotechnology with a Buy rating and a $15 price target.
  • The Michaels Companies, Inc. MIK gained 8.4% to $6.59.
  • Signet Jewelers Limited SIG gained 8.4% to $19.40 on continued strength from Thursday's earnings report. Wells Fargo raised the price target to $16/share but said the company's core fundamental business remains 'pressured.'
  • Realogy Holdings Corp. RLGY climbed 8% to $10.52 after moving back above the $10 level. Not currently seeing any company-specific news.
  • Cloudera, Inc. CLDR rose 7.7% to $10.78 after the company reported upbeat quarterly earnings.
  • Tantech Holdings Ltd TANH gained 7.3% to $2.20.
  • Sage Therapeutics, Inc. SAGE rose 7.2% to $64.50 after falling 59.67% on Thursday. SVB Leerink upgraded Sage Therapeutics from Underperform to Market Perform.
  • Kiniksa Pharmaceuticals, Ltd. KNSA rose 7.2% to $10.69. Goldman Sachs upgraded Kiniksa Pharmaceuticals from Neutral to Buy and raised the price target from $16 to $18.
  • InMode Ltd. INMD gained 6.7% to $46.50 in sympathy with the overall market amid a rally in US equities following strong November jobs data.
  • Adverum Biotechnologies, Inc. ADVM gained 6.7% to $11.25 in sympathy with the overall market after a rally in US equities following strong November jobs data.
  • Trade Desk Inc TTD rose 5.5% to $253.68. Needham upgraded Trade Desk from Hold to Buy and announced a $325 price target.
  • DocuSign, Inc. DOCU rose 4.1% to $72.36 after reporting better-than-expected Q3 earnings results.


Check out these big penny stock gainers and losers

Losers

  • Correvio Pharma Corp. CORV shares dipped 33.9% to $1.4283.
  • Oyster Point Pharma, Inc. OYST shares fell 16% to $15.51.
  • Yext, Inc. YEXT fell 15.2% to $14.07 after the company reported worse-than-expected Q3 EPS results and issued weak forecast.
  • IMAC Holdings, Inc. IMAC dropped 13.5% to $1.7296.
  • Liquid Media Group Ltd. YVR dipped 13.3% to $2.55.
  • ASLAN Pharmaceuticals Limited ASLN fell 10.8% to $2.22 on continued downward momentum after the company priced a 5.2 million ADS offering at $2.50 per ADS.
  • Cortexyme, Inc. CRTX dropped 10.8% to $30.60.
  • PagerDuty, Inc. PD shares fell 10.3% to $22.41 after the company reported worse-than-expected Q3 EPS results. The company also issued Q4 and FY20 EPS guidance below analyst estimates.
  • Zoom Video Communications, Inc. ZM fell 10.3% to $62.51 after the company reported Q3 earnings results. The company also issued Q4 and FY20 guidance.
  • Intercept Pharmaceuticals, Inc. ICPT dipped 10.2% to $107.54. Intercept announced publication of results from the interim analysis of the Phase 3 REGENERATE study of OCA for the treatment of fibrosis due to NASH in The Lancet.
  • DarioHealth Corp DRIO fell 9.4% to $7.70.
  • China Automotive Systems, Inc. CAAS fell 8.7% to $3.56.
  • Eloxx Pharmaceuticals, Inc. ELOX dropped 8.4% to $5.25.
  • Proteostasis Therapeutics, Inc. PTI dipped 8.2% to $3.4808.
  • IDT Corporation IDT fell 8% to $6.90 following Q1 results.
  • Guidewire Software Inc GWRE fell 6.4% to $111.67 after the company issued Q2 sales guidance below analyst estimates.
  • Weidai Ltd. WEI fell 5% to $4.24 after declining 10.29% on Thursday.
  • Ciena Corporation CIEN fell 4.7% to $34.58. UBS downgraded Ciena from Neutral to Sell and lowered the price target from $43 to $31.
  • Xinyuan Real Estate Co., Ltd. XIN fell 4.4% to $3.7389 following Q3 results.
Loading...
Loading...
Posted In: NewsMovers & ShakersIntraday UpdateMarketsMoversTrading IdeasGeneralBiotechnologyHealth CareMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...